GGrantIndex
Sort

78,016 grants matching breast cancer

Role of T-box genes in mouse development

$448,533
Virginia E. Papaioannou · Columbia University Health Sciences · R37 · FY2016 · HD

Patient Data and Sample Collection and Distribution and Pathology Review Facility

$448,519
Louise C Strong · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA

Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance

$448,510
Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA

Body Size, Physical Activity and Breast Cancer Subtypes

$448,466
Lynn Rosenberg · Roswell Park Cancer Institute Corp · P01 · FY2015 · CA

Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients

$448,440
Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2022 · CA

Measurement Errors in Cancer Epidemiology

$448,399
Donna L Spiegelman · Harvard School Of Public Health · R01 · FY2013 · CA

Microsampling Unit for Capturing Low Abundant Cells

$448,397
Steven A. Soper · Louisiana State Univ A&M Col Baton Rouge · R33 · FY2006 · CA

Metarrestin for the Treatment of Pancreatic Cancer

$448,357
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR

Transport Oncophysics Core

$448,357
Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA

Deciphering the tumor suppressive functions of macroH2A

$448,328
Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA

Deciphering the tumor suppressive functions of macroH2A

$448,328
Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA

IN VIVO RNAI SCREENS TO IDENTIFY NOVEL T CELL-DEPENDENT IMMUNOTHERAPEUTIC TARGETS OF BREAST CANCER

$448,326
Scripps Research Institute, The · · FY2016 · Department of the Army

The Genetics of Susceptibility to Mouse Plasma Cell Tumors

$448,310
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Biopsychosocial predictors of tumor-associated inflammation and progression

$448,308
Eida Maria Castro · Ponce School Of Medicine · U54 · FY2022 · MD

TGF-beta Suppression and Promotion of Mammary Carcinomas

$448,305
Harold L Moses · Vanderbilt University · R01 · FY2012 · CA

PROGRAM LEADERS

$448,297
Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2010 · CA

Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer

$448,182
Louise C Showe · Wistar Institute · U01 · FY2021 · CA

A Novel Physiologically Based Pharmacokinetic (PBPK) Modeling Approach to Facilitate Safer Medications During Lactation

$448,182
Tao Zhang · State University Of Ny,Binghamton · R21 · FY2025 · HD

ERa is a novel RNA-binding protein controlling breast cancer

$448,158
Davide Ruggero · University Of California, San Francisco · R01 · FY2024 · CA

MOLECULAR AND IMAGING BIOMARKERS FOR PRECISION THERAPY OF BREAST CANCER

$448,153
Sunnybrook Research Institute · · FY2018 · Department of the Army

Stress Induction of Glucose Regulated Protein GRP78/BiP

$448,140
Amy S Lee · University Of Southern California · R01 · FY2019 · CA

Transcription factor mutants of yeast

$448,126
Karen M Arndt · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · GM

Anatomic and Biologic Staging of Breast Disease with MRI

$448,122
Nola M. Hylton · University Of California, San Francisco · R01 · FY2009 · CA

Evaluation of the Implementation and Effectiveness of the American College of Surgeons Operative Standards Program

$448,059
Lesly A Dossett · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Imaging Habitats in Sarcoma

$448,046
Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · CA